In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the ...

Moderna's MRNA.O mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on ...

The efficacy of flu shots is not always the same and it’s not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%. Subscribe to read this story ad-free Get ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: Mashable Photo ...

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies ...

RICHMOND, Va. (WRIC) — A woman was shot following a disturbance with students and parents that started at a Richmond high school and ended in a fight at a different location, according to police. On ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Production has officially wrapped on the sequel series to the classic sitcom “A Different World,” according to Tudum, marking a major step forward for one of television’s most influential portrayals ...

Production on Netflix‘s A Different World sequel series has concluded in Atlanta, and news of new castings has emerged. Two additional original A Different World cast members will reprise their roles: ...

Spectators watched as a large rocket booster sailed into Port Canaveral Wednesday afternoon. This was not the usual SpaceX Falcon 9 booster but Blue Origin's New Glenn returning for a second time.

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines. In the phase ...